Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes

Blood

Volumn 112, Issue 7, 2008, Pages 2657-2666

  Kisand, Kai ^a   Link, Maire ^a   Wolff, Anette S B ^b   Meager, Anthony ^c   Tserel, Liina ^a   Org, Tonis ^a   Murumägi, Astrid ^d   Uibo, Raivo ^a   Willcox, Nick ^e   Podkrajšek, Katarina Trebušak ^f   Battelino, Tadej ^f   Lobell, Anna ^g   Kämpe, Olle ^g   Lima, Kari ^h   Meloni, Antonella ⁱ   Ergun Longmire, Berrin ^j   Maclaren, Noel K ^k   Perheentupa, Jaakko ^l   Krohn, Kai J E ^m   Scott, Hamish S ^n,o   Eystein S Husebye, ^b,p   Peterson, Pärt ^a   more..

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF BERGEN   (Norway)

^c NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^d UNIVERSITY OF TAMPERE   (Finland)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

^g UPPSALA UNIVERSITY   (Sweden)

^h AKERSHUS UNIVERSITY HOSPITAL   (Norway)

ⁱ UNIVERSITY OF CAGLIARI   (Italy)

^j ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^k Bioseek Clinics   (United States)

^l UNIVERSITY OF HELSINKI   (Finland)

^m Dermagene Oy   (Finland)

ⁿ WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^o INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^p HAUKELAND UNIVERSITY HOSPITAL   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; AUTOIMMUNE REGULATOR PROTEIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON; INTERFERON ANTIBODY; NEUTRALIZING ANTIBODY; OMEGA INTERFERON; STAT PROTEIN; UNCLASSIFIED DRUG; STAT1 PROTEIN; TRANSCRIPTION FACTOR;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; BLOOD CELL; CELL CULTURE; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENOME; HUMAN; HUMAN CELL; MALE; MICROARRAY ANALYSIS; MONOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; AUTOIMMUNE POLYENDOCRINOPATHY; BIOLOGICAL MODEL; BLOOD; CASE CONTROL STUDY; CELL LINE; DNA MICROARRAY; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PHOSPHORYLATION; SERODIAGNOSIS;

ADOLESCENT; ADULT; AUTOANTIBODIES; BLOOD CELLS; CASE-CONTROL STUDIES; CELL LINE; CHEMOKINE CXCL10; DENDRITIC CELLS; DOWN-REGULATION; FEMALE; HUMANS; INTERFERON TYPE I; INTERFERONS; MALE; MIDDLE AGED; MODELS, IMMUNOLOGICAL; MONOCYTES; NEUTRALIZATION TESTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; POLYENDOCRINOPATHIES, AUTOIMMUNE; STAT1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS;

EID: 51349111750     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-03-144634     Document Type: Article

References (47)

1. Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev. 2004;202:8-32.
2. Baccala R, Kono DK Theofilopoulos AN. Interferons as pathogenic effectors in autoimmunity. Immunol Rev. 2005;204:9-26.
3. Saksela E, Virtanen I, Hovi T, Secher DS, Cantell K. Monocyte is the main producer of human leukocyte alpha interferons following Sendai virus induction. Prog Med Virol. 1984;30:78-86.
4. Liu YJIPG: professional type 1 interferonproducing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol. 2005;23:275-306.
5. Blanco P, Palucka AK, Pascual V, Banchereau J. Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev. 2008;19:41-52.
6. Honda K, Yanai H, Negishi H, et al. IRF-7 is the master regulator of type-l interferon-dependent immune responses. Nature. 2005;434:772-777.
7. Ronnblom L, Alm GV. An etiopathogenic role for the type I IFN system in SLE. Trends Immunol. 2001;22:427-431.
8. Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity. 2006;25:383-392.
9. Pascual V, Farkas L, Banchereau J. Systemic lupus erythematosus: all roads lead to type I interferons. Curr Opin Immunol. 2006;18:676-682.
10. Meager A, Visvalingam K, Peterson P, et al. Antiinterferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med. 2006; 3:e289.
11. Sillanpaa N, Magureanu GG, Murumagi A, et al. Autoimmune regulator induced changes in the gene expression profile of human monocytedendritic cell-lineage. Mol Immunol. 2004;41: 1185-1198.
12. Nagamine K, Peterson P, Scott HS, et al. Positional cloning of the APECED gene. Nat Genet. 1997;17:393-398.
13. Kyewski B, Derbinski J. Self-re presentation in the thymus: an extended view. Nat Rev Immunol. 2004;4:688-698.
14. Mathis D, Benoist C. A decade of AIRE. Nat Rev Immunol. 2007;7:645-650.
15. Cheng MH. Shum AK, Anderson MS. What's new in the Aire? Trends Immunol. 2007;28:321-327.
16. Heino M. Peterson P. Sillanpaa N. et al. RNA and protein expression of the murine autoimmune regulator gene (Aire) in normal, RelB-deficient and in NOD mouse. Eur J Immunol. 2000;30: 1884-1893.
17. Perheentupa J. Autoimmune polyendocrinopathycandidiasis-ectodermal dystrophy. J Clin Endocrinol Metab. 2006;91:2843-2850.
18. Peterson P, Peltonen L. Autoimmune polyendocrinopathy syndrome type 1 (APS1) and AIRE gene: new views on molecular basis of autoimmunity. J Autoimmun. 2005;25(suppl):S49-S55.
19. Zhang L, Barker JM, Babu S, et al. A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1. Clin Immunol. 2007;125:131-137.
20. Pontynen N, Miettinen A, Arstila TP, et al. Aire deficient mice do not develop the same profile of tissue-specific autoantibodies as APECED patients. J Autoimmun. 2006;27:96-104.
21. Meager A, Wadhwa M, Dilger P, et al. Anticytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis. Clin Exp Immunol. 2003;132:128-136.
22. Romani N, Reider D, Heuer M, et al. Generation of mature dendritic cells from human blood: an improved method with special regard to clinical applicability. J Immunol Methods. 1996;196:137-151.
23. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003;31:e15.
24. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat AppI Genet Mol Biol. 2004;3:Article 3.
25. Wolff AS, Erichsen MM, Meager A, et al. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. J Clin Endocrinol Metab. 2007;92:595-603.
26. de Veer MJ, Holko M, Frevel M, et al. Functional classification of interieron-stimulated genes identified using microarrays. J Leukoc Biol. 2001;69: 912-920.
27. Taylor MW, Tsukahara T, Brodsky L, et al. Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy. J Virol. 2007;81: 3391-3401.
28. Antonelli A, Rotondi M, Fallahi P, et al. High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism. J Clin Endocrinol Metab. 2004; 89:5496-5499.
29. Romagnani P, Rotondi M, Lazzeri E, et al. Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease. Am J Pathol. 2002;161:195-206.
30. Rotondi M, Falorni A, De Bellis A, et al. Elevated serum interferon-gamma-inducible chemokine-10/CXG chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines. J Clin Endocrinol Metab. 2005;90:2357-2363.
31. Kirou KA, Lee C, George S, et al. Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. Arthritis Rheum. 2004;50:3958-3967.
32. Taniguchi T, Takaoka A. A weak signal for strong responses: interferon-alp ha/beta revisited. Nat Rev Mol Cell Biol. 2001;2:378-386.
33. Niewold TB, Hua J, Lehman TJ, Harley JB. Crow MK. High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun. 2007;8:492-502.
34. Tovey MG, Streuli M, Gresser I, et al. Interferon messenger RNA is produced constitutively in the organs of normal individuals. Proc Natl Acad Sci U S A. 1987;84:5038-5042.
35. Bauer JW, Baechler EC, Petri M, et al. Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Med. 2006;3:e491.
36. Feferman T, Maiti PK, Berrih-Aknin S, et al. Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis. J Immunol. 2005;174:5324-5331.
37. Buttmann M, Merzyn G, Rieckrnann P. Interferonbeta induces transient systemic IP-10/CXCL10 Ghemokine release in patients with multiple sclerosis. J Neuroimmunol. 2004;156:195-203.
38. KrakauerM, Sorensen PS, Khademi M, Olsson T Sellebjerg F. Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis. Scand J Immunol. 2006;64:155-163.
39. Migita K, MiyashitaT, MaedaY, et al. Reduced blood BDCA-2 + (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus. Clin Exp Immunol. 2005;142:84-91.
40. Tomer Y, Blackard JT; Akeno N. Interferon alpha treatment and thyroid dysfunction. Endocrinol Metab Clin North Am. 2007;36:1051-1066.
41. Coccia EM, Severa M, Giacomini E, et al. Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocytederived dendritic cells. Eur J Immunol. 2004;34: 796-805.
42. Walker J, Tough DF. Modification of TLR-induced activation of human dendritic cells by type I IFN: synergistic interaction with TLR4 but not TLR3 agonists. Eur J Immunol. 2006;36:1827-1836.
43. Bendriss-Vermare N, Barthelemy C, Durand I, et al. Human thymus contains IFN-alpha-producing CD11c(-), myeloid CD11c(+), and mature interdigitating dendritic cells. J Clin Invest. 2001;107: 835-844.
44. Schmidlin H, Dontje W, Groot F, et al. Stimulated plasmacytoid dendritic cells impair human T-cell development. Blood. 2006;108:3792-3800.
45. Vidalain PO, Laine D. Zaffran Y, et al. Interferons mediate terminal differentiation of human cortical thymic epithelial cells. J Virol. 2002;76:6415-6424.
46. Gray D;Abramson J, Benoist C, Mathis D. Proliferative arrest and rapid turnover of thymic epithelial cells expressing Aire. J Exp Med. 2007:204: 2521-2528.
47. Strobel P, Murumagi A, Klein R, et al. Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1). J Pathol. 2007;211: 563-571.